Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 434,808 shares at $20.49 ($9.0M) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Open-market sale of $9.0M EXEL by EVP, Scientific Strategy & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.49 | 100,000 | $2.0M | 22.9% |
| 2 | $20.49 | 100,000 | $2.0M | 22.9% |
| 3 | $20.76 | 17,404 | $361K | 4.0% |
| 4 | $20.76 | 17,404 | $361K | 4.0% |
| 5 | $20.67 | 100,000 | $2.1M | 23.1% |
| 6 | $20.67 | 100,000 |
| $2.1M |
| 23.1% |
| Total | $20.59 avg | 434,808 | $9.0M | 100% |
| Filing → |
| EXEL | SELL | 2021-11-17 | $859K | — | Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |